| Neurofilament light chain in blood and CSF as marker of disease progression in mouse models and in neurodegenerative diseases M Bacioglu, LF Maia, O Preische, J Schelle, A Apel, SA Kaeser, ... Neuron 91 (1), 56-66, 2016 | 409 | 2016 |
| Three decades of comprehensive geriatric assessment: evidence coming from different healthcare settings and specific clinical conditions A Pilotto, A Cella, A Pilotto, J Daragjati, N Veronese, C Musacchio, ... Journal of the American Medical Directors Association 18 (2), 192. e1-192. e11, 2017 | 395 | 2017 |
| Steroid‐responsive encephalitis in coronavirus disease 2019 A Pilotto, S Odolini, S Masciocchi, A Comelli, I Volonghi, S Gazzina, ... Annals of neurology 88 (2), 423-427, 2020 | 314 | 2020 |
| A multicentre validation study of the diagnostic value of plasma neurofilament light NJ Ashton, S Janelidze, A Al Khleifat, A Leuzy, EL van der Ende, ... Nature Communications 12 (1), 1-12, 2021 | 286 | 2021 |
| Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy A Benussi, A Pilotto, E Premi, I Libri, M Giunta, C Agosti, A Alberici, ... Neurology 95 (7), e910-e920, 2020 | 262 | 2020 |
| Long-term unsupervised mobility assessment in movement disorders E Warmerdam, JM Hausdorff, A Atrsaei, Y Zhou, A Mirelman, K Aminian, ... The Lancet Neurology 19 (5), 462-470, 2020 | 206 | 2020 |
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Encephalitis Is a Cytokine Release Syndrome: Evidences From Cerebrospinal Fluid Analyses A Pilotto, S Masciocchi, I Volonghi, V De Giuli, F Caprioli, S Mariotto, ... Clinical Infectious Diseases 73 (9), e3019-e3026, 2021 | 146* | 2021 |
| Long-term neurological manifestations of COVID-19: prevalence and predictive factors A Pilotto, V Cristillo, S Cotti Piccinelli, N Zoppi, G Bonzi, D Sattin, ... Neurological Sciences 42 (12), 4903-4907, 2021 | 143* | 2021 |
| Effect of a CYP2D6 polymorphism on the efficacy of donepezil in patients with Alzheimer disease A Pilotto, M Franceschi, G D’Onofrio, A Bizzarro, F Mangialasche, ... Neurology 73 (10), 761-767, 2009 | 127 | 2009 |
| Clinical Presentation and Outcomes of Severe Acute Respiratory Syndrome Coronavirus 2–Related Encephalitis: The ENCOVID Multicenter Study A Pilotto, S Masciocchi, I Volonghi, M Crabbio, E Magni, V De Giuli, ... The Journal of Infectious Diseases 223 (1), 28-37, 2021 | 119* | 2021 |
| Application of the movement disorder society prodromal Parkinson's disease research criteria in 2 independent prospective cohorts A Pilotto, S Heinzel, U Suenkel, S Lerche, K Brockmann, B Roeben, ... Movement Disorders 32 (7), 1025-1034, 2017 | 93 | 2017 |
| Central serous chorioretinopathy: pathogenesis and management F Semeraro, F Morescalchi, A Russo, E Gambicorti, A Pilotto, ... Clinical Ophthalmology (Auckland, NZ) 13, 2341, 2019 | 88 | 2019 |
| Orthostatic hypotension and REM sleep behaviour disorder: impact on clinical outcomes in α-synucleinopathies A Pilotto, A Romagnolo, JA Tuazon, JA Vizcarra, L Marsili, M Zibetti, ... Journal of Neurology, Neurosurgery & Psychiatry 90 (11), 1257-1263, 2019 | 76 | 2019 |
| Role of cytochrome P4502D6 functional polymorphisms in the efficacy of donepezil in patients with Alzheimer's disease D Seripa, A Bizzarro, A Pilotto, G D'Onofrio, G Vecchione, AP Gallo, ... Pharmacogenetics and genomics 21 (4), 225-230, 2011 | 74 | 2011 |
| Brain glucose metabolism in Lewy body dementia: implications for diagnostic criteria SP Caminiti, A Sala, L Iaccarino, L Beretta, A Pilotto, L Gianolli, ... Alzheimer's research & therapy 11 (1), 1-14, 2019 | 71 | 2019 |
| Altered brain metabolic connectivity at multiscale level in early Parkinson’s disease A Sala, SP Caminiti, L Presotto, E Premi, A Pilotto, R Turrone, ... Scientific reports 7 (1), 1-12, 2017 | 70 | 2017 |
| Pharmacogenetics of cytochrome P450 (CYP) in the elderly D Seripa, A Pilotto, F Panza, MG Matera, A Pilotto Ageing research reviews 9 (4), 457-474, 2010 | 70 | 2010 |
| Agitation and dementia: prevention and treatment strategies in acute and chronic conditions C Carrarini, M Russo, F Dono, F Barbone, MG Rispoli, L Ferri, M Di Pietro, ... Frontiers in neurology 12, 644317, 2021 | 68 | 2021 |
| Vascular risk factors and cognition in Parkinson’s disease A Pilotto, R Turrone, I Liepelt-Scarfone, M Bianchi, L Poli, B Borroni, ... Journal of Alzheimer's Disease 51 (2), 563-570, 2016 | 65 | 2016 |
| Pharmacological strategies for the management of levodopa-induced dyskinesia in patients with Parkinson’s disease E Schaeffer, A Pilotto, D Berg CNS drugs 28 (12), 1155-1184, 2014 | 65 | 2014 |
Alessandro PadovaniDipartimento Scienze Cliniche e SperimentaliVerified email at unibs.it
